Related Experiment Videos
[Surgical treatment for mitral valve prolapse]
1Department of Thoracic and Cardiovascular Surgery, Second Affiliated Hospital, Hunan Medical University, Changsha 410011.
Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|September 6, 2002
Summary
For mitral valve prolapse (MVP), using expanded polytetrafluorethylene (e-PTFE) sutures with artificial ring valvuloplasty offers a safer and more reliable surgical repair than traditional methods. This approach also avoids long-term anticoagulant therapy risks.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Repair
- Biomaterials in Medicine
Background:
- Mitral valve prolapse (MVP) is a common valvular heart disease.
- Effective surgical treatment for MVP aims to restore valve function and prevent complications.
- Traditional reconstruction methods may have limitations in long-term efficacy.
Purpose of the Study:
- To compare the effectiveness of different surgical procedures for treating mitral valve prolapse (MVP).
- To identify the optimal operative technique for mitral valve repair or replacement.
Main Methods:
- A comparative study involving 57 patients with MVP.
- Group I: Traditional chordal reconstruction.
- Group II: Chordal replacement with expanded polytetrafluorethylene (e-PTFE) sutures and artificial ring valvuloplasty.
- Group III: Mitral valve replacement.
Main Results:
- Significant reduction in mitral regurgitation volume observed in Group II and Group III compared to Group I (P < 0.05).
- Group II and Group III demonstrated superior outcomes in mitigating regurgitation.
- The e-PTFE suture and ring valvuloplasty group showed promising results in valve function restoration.
Conclusions:
- Expanded polytetrafluorethylene (e-PTFE) sutures as artificial chordae combined with artificial ring valvuloplasty represent a reliable and safe surgical option for MVP.
- This technique offers an advantage over traditional reconstruction by improving valve function.
- It also provides an alternative to mechanical valve replacement, thereby avoiding the need for long-term anticoagulant therapy.